Tevogen (TVGN) Preferred Shares (2024 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Preferred Shares came in at $6.0 million in Q1 2026, little changed YoY from $6.0 million in Q1 2025, and up 114.29% on a QoQ basis from $2.8 million in Q4 2025.
Tevogen (TVGN) Preferred Shares (2024 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 3 years of Preferred Shares data on file, last reported at $6.0 million in Q1 2026.
- Quarterly Preferred Shares changed 0.0% year-over-year to $6.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $2.8 million, changed 0.0% from the prior year.
- Preferred Shares rose to $6.0 million in Q1 2026, from $2.8 million in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $6.0 million in Q1 2025 to a low of $2.8 million in Q2 2024.
- A 3-year average of $4.4 million and a median of $4.0 million in 2024 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 114.29% in 2025, down 0.0% in 2025.
- Tracing TVGN's Preferred Shares over 3 years: stood at $2.8 million in 2024, then changed by 0.0% to $2.8 million in 2025, then surged by 114.29% to $6.0 million in 2026.
- The last three Preferred Shares figures came in at $6.0 million (Q1 2026), $2.8 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Tevogen | 25.62 Mn | 25.62 Mn | - | 6.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.82 Mn |
| Mar 31, 2026 | 6.00 Mn |
| Dec 31, 2025 | 2.80 Mn |
| Sep 30, 2025 | 6.00 Mn |
| Jun 30, 2025 | 6.00 Mn |
| Mar 31, 2025 | 6.00 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 3.61 Mn |